Papers using
Arginase
antibodies
Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene.Appanna Vasu D., In PLoS ONE, 1999
... including pregnenolone 16α-carbonitrile (PCN, 10 µM; Sigma) for PXR, 1,4-Bis-[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP, 250 nM; Sigma) for CAR, β-estradiol (10 nM; Sigma) for ER, T0901317 (1 µM; Cayman Chemical) for LXRα, calcipotriol ...
Papers on
Arginase
Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.McBride et al., Memphis, United States. In Ann Hematol, Feb 2016
A literature search identified published Phase I-III clinical trials of monoclonal antibodies (otlertuzumab, brentuximab, obinutuzumab, ibritumomab, ofatumumab); tyrosine kinase inhibitors (alvocidib [flavopiridol], dinaciclib, ibrutinib, nilotinib, dasatinib, idelalisib, venetoclax [ABT-199]); proteasome inhibitors (oprozomib, carfilzomib); chimeric antigen receptor (CAR) T cells; and the proapoptotic agent lenalidomide.
Shifting the Evolving CAR T Cell Platform into Higher Gear.Bluestone et al., San Francisco, United States. In Cancer Cell, Nov 2015
In this issue of Cancer Cell, Zhao and colleagues test various chimeric antigen receptor (CAR) T cells to show that CD28-CD3ζ CAR T cells that constitutively express 4-1BBL promote T cell expansion and tumor eradication while reducing exhaustion.